Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestat von Li, Qingqin S, Francke, Stephan, Snoeys, Jan, Thipphawong, John, Romano, Gary, Novak, Gerald P

Volltext

Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-b... von Sanga, Panna, MD, Polverejan, Elena, PhD, Wang, Steven, PhD, Kelly, Kathleen M., MD, Thipphawong, John, MD

Volltext

A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain von Hanna, Magdi, Thipphawong, John

Volltext

Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of... von Hale, Martin, MD, Tudor, Iulia Cristina, PhD, Khanna, Sarita, PhD, Thipphawong, John, MD

Volltext

Analgesic efficacy of inhaled morphine in patients after bunionectomy surgery von THIPPHAWONG, John B, BABUL, Najib, MORISHIGE, Richard J, FINDLAY, Hugh K, REBER, Keith R, MILLWARD, Gary J, OTULANA, Babatunde A

Volltext

An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain von Hanna, Magdi, Tuca, Alberto, Thipphawong, John

Volltext

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial von Sperling, Reisa, Henley, David, Aisen, Paul S, Raman, Rema, Donohue, Michael C, Ernstrom, Karin, Rafii, Michael S, Streffer, Johannes, Shi, Yingqi, Karcher, Keith, Raghavan, Nandini, Tymofyeyev, Yevgen, Bogert, Jennifer, Brashear, H. Robert, Novak, Gerald, Thipphawong, John, Saad, Ziad S, Kolb, Hartmuth, Rofael, Hany, Sanga, Panna, Romano, Gary

Volltext

Inhaled cytokines and cytokine antagonists von Thipphawong, John

Volltext

Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain von Sanga, Panna, Katz, Nathaniel, Polverejan, Elena, Wang, Steven, Kelly, Kathleen M., Haeussler, Juergen, Thipphawong, John

Volltext

Clinical Trial Results with OROS® Hydromorphone von Wallace, Mark S., MD, Thipphawong, John, MD

Volltext

Long‐Term Safety and Efficacy of Fulranumab in Patients With Moderate‐to‐Severe Osteoarthritis Pain: A Phase II Randomized, Double‐Blind, Placebo‐Controlled Extension Study... von Sanga, Panna, Katz, Nathaniel, Polverejan, Elena, Wang, Steven, Kelly, Kathleen M., Haeussler, Juergen, Thipphawong, John

Volltext

Poster 269: Open-label Extension Study on the Long-Term Safety, Impact on Quality of Life and Clinical Utility of OROS® Hydromorphone Extended Release in Patients with Chronic Low... von Wallace, Mark S., Thipphawong, John

Volltext

Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study von Slatkin, Neal, Zaki, Naim, Wang, Steven, Louie, John, Sanga, Panna, Kelly, Kathleen M., Thipphawong, John

Volltext

Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study von Wang, Hao, Russell, Lucille J, Kelly, Kathleen M, Wang, Steven, Thipphawong, John

Volltext

Open-Label Study on the Long-Term Efficacy, Safety, and Impact on Quality of Life of OROS Hydromorphone ER in Patients with Chronic Low Back Pain von Wallace, Mark, Thipphawong, John

Volltext

Inhaled cytokines and cytokine antagonists: Challenges and innovations in effective pulmonary systemic and macromolecular drug delivery von THIPPHAWONG, John

Volltext

Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial von Wang, Hao, Romano, Gary, Frustaci, Mary Ellen, Bohidar, Norm, Ma, Huizhong, Sanga, Panna, Ness, Seth, Russell, Lucille J, Fedgchin, Margaret, Kelly, Kathleen M, Thipphawong, John

Volltext

Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Pla... von Wang, Hao, Romano, Gary, Fedgchin, Margaret, Russell, Lucille, Sanga, Panna, Kelly, Kathleen M, Frustaci, Mary Ellen, Thipphawong, John

Volltext

Results of a Double-blind, Placebo-controlled, Fixed-dose Assessment of Once-daily OROS® Hydromorphone ER in Patients with Moderate to Severe Pain Associated with Chronic Osteoarth... von Rauck, Richard, Rapoport, Ronald, Thipphawong, John

Volltext

FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER’S DISEASE von Henley, David, Sperling, Reisa A., Aisen, Paul S., Raman, Rema, Donohue, Michael C., Ernstrom, Karin, Shi, Yingqi, Karcher, Keith, Raghavan, Nandini, Tymofyeyev, Yevgen, Brashear, Robert, Novak, Gerald P., Thipphawong, John, Saad, Ziad, Kolb, Hartmuth C., Romano, Gary

Volltext